Expensive new blood pressure meds no better than generics

Aug 12, 2010

Expensive brand-name medications to lower blood pressure are no better at preventing cardiovascular disease than older, generic diuretics, according to new long-term data from a landmark study.

Paul Whelton, MB, MD, MSc, reported the results on Aug. 13 at the plenary session of the China Heart Congress and International Heart Forum in Beijing. Whelton is president and CEO of Loyola University Health System and chairman of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heat Attack Trial (ALLHAT), which has examined the comparative value of different blood pressure-lowering medications.

More than 33,000 patients with high blood pressure were randomly assigned to take either a diuretic (chlorthalidone) or one of two newer drugs, a calcium channel blocker (amlodipine) or an ACE inhibitor (lisinopril).

In 2002, ALLHAT researchers reported that among patients followed for four-to-eight years, the diuretic was better than the calcium channel blocker in preventing heart failure and better than the ACE inhibitor in preventing stroke, heart failure and overall cardiovascular disease.

In the new study, researchers followed ALLHAT participants for an additional four to five years after completion of the trial, bringing the total follow-up period to between eight and 13 years. During this longer follow-up period, the differences between the three drugs narrowed -- by most measures they were a statistical dead heat.

But the diuretic still was superior in two measures: Compared with the diuretic group, the ACE inhibitor group had a 20 percent higher death rate from stroke, and the calcium channel blocker group had a 12 percent higher rate of hospitalizations and deaths due to .

Diuretics, sometimes called "water pills," are the traditional medications for high blood pressure. They cause kidneys to remove sodium and water from the body, thereby relaxing . such as lisinopril (brand names, Prinivil® and Zestril®) decrease chemicals that tighten blood vessels. Calcium channel blockers such as amlodipine (brand name, Norvasc®) relax blood vessels.

Diuretics cost $25 to $40 per year, while newer brand-name hypertension drugs can cost $300 to $600 per year.

The National Heart, Lung and Blood Institute recommends patients control their blood pressure by first controlling their weight, exercising, reducing sodium, increasing potassium and drinking alcohol in moderation. The institute says that if lifestyle changes are not sufficient, diuretics then normally should be the drug of first choice.

However, newer, higher-priced drugs are heavily marketed, and diuretics account for only about 30 percent of prescriptions written for high blood pressure medications, Whelton said.

Whelton is senior author of a study published in the May 24, 2010, Archives of Internal Medicine that found that using techniques similar to those employed by pharmaceutical sales reps can help persuade doctors to prescribe diuretics.

Like drug sales representatives, researchers in the study met with small groups of doctors, especially opinion leaders. They detailed guidelines for treating high , and handed out studies, newsletters, exam room posters, etc. An examination of prescribing patterns found that this technique, known as "academic detailing," influenced what drugs doctors prescribed.

ALLHAT is sponsored by the National Heart, Lung and Blood Institute. "We are continuing to mine data that we collected during the trial," Whelton said.

Explore further: Novel regulatory mechanism for cell division found

add to favorites email to friend print save as pdf

Related Stories

New research confirms milestone study on blood pressure meds

May 13, 2009

New research supports the findings of a landmark drug comparison study published in 2002 in which a diuretic drug or "water pill" outperformed other medications for high blood pressure. A scientific team including investigators ...

High blood pressure pill cuts risk of Parkinson's disease

Feb 06, 2008

People taking a widely used group of drugs known as calcium channel blockers to treat high blood pressure also appear to be cutting their risk of Parkinson’s disease, according to a study published in the February 6, 2008, ...

Recommended for you

Organovo has 3D-printed liver tissue for drug testing

20 hours ago

(Medical Xpress)—The commercial release of 3D printed liver tissue was announced earlier this week. Organovo is the company behind the release. The product is intended for use for preclinical drug discovery ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

VOR
not rated yet Sep 06, 2010
US drug development is terribly flawed by its capitalist structure. The theory that 'the market' will demand the best products breaks down when dealing with things that consumers cant judge for themselves. Drugs are the best example of that. We must recognize that good drug development and profit seeking will always be at odds, and even with (regulatory and other)efforts to reduce the conflict, it is fundamentally flawed.
While its true a good drug can make money, more often and more likely, its a well-marketed drug that makes money, regardless of its safetly and effectiveness relative to others. Thats the fact. Spread the word. Marketing is not only non-beneficial to health, its wasteful. What can be done immediately? Ban ALL drug marketing, especially to the public. But even to doctors. Establish a non-profit go-between agency (manned by doctors/researches with no financial interest in drugs) that rates and catalogs drugs. (steps to eventual socialization of drug development).

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.